MOS
32
3
NUE
54
-4
HPQ
37
2
AMP
70
4
CHRW
79
-3
FSLR
78
5
HIG
70
2
ICE
60
3
APD
50
5
DHR
68
2
BRK.B
40
7
DLTR
58
-5
WHR
48
-2
CAG
34
-2
PSX
25
-12
PRU
60
-2
FLS
63
2
AMAT
54
2
STX
64
-5
TRIP
52
3
MOS
32
3
NUE
54
-4
HPQ
37
2
AMP
70
4
CHRW
79
-3
FSLR
78
5
HIG
70
2
ICE
60
3
APD
50
5
DHR
68
2
BRK.B
40
7
DLTR
58
-5
WHR
48
-2
CAG
34
-2
PSX
25
-12
PRU
60
-2
FLS
63
2
AMAT
54
2
STX
64
-5
TRIP
52
3
Financhill
Back

Keros Therapeutics, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
60

KROS
Keros Therapeutics, Inc.

Last Price:
$21.34
Seasonality Move:
4.91%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$42.83
Seasonality Move:
0.59%
Buy
60
Keros Therapeutics, Inc. (KROS) is a Buy

Is Keros Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Keros Therapeutics, Inc. [KROS] share price is $21.34. The Score for KROS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KROS Stock Price Chart

What is Keros Therapeutics, Inc.'s stock price today?

  • The Keros Therapeutics, Inc. share price today is $21.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.08 Buy
Relative Strength Index (14 RSI): 64.89 Buy
Chaikin Money Flow: 429198 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.3 - 21.3) Buy
Bollinger Bands (100): (14.21 - 18.45) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 61.08 Buy
Chaikin Money Flow: 587345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 39.82) Buy
Bollinger Bands (100): (17.72 - 34.64) Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.07 Buy
20-day SMA: 19.83 Buy
50-day SMA: 17.44 Buy
200-day SMA: 14.8 Buy
8-day EMA: 20.83 Buy
20-day EMA: 19.96 Buy
50-day EMA: 18.24 Buy
200-day EMA: 18.69 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.46 Buy
20-day SMA: 37.97 Buy
50-day SMA: 33.51 Buy
200-day SMA: 18.21 Buy
8-day EMA: 24.11 Buy
20-day EMA: 12.41 Buy
50-day EMA: 5.54 Buy
200-day EMA: 1.47 Buy

Keros Therapeutics, Inc. Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and a decrease next year of $5.27 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Keros Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):